NCT02639325 2026-03-11Tumor Related EpilepsyNational Institutes of Health Clinical Center (CC)Recruiting100 enrolled
NCT02962414 2026-02-03Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued TreatmentNovartisPhase 3 Active not recruiting206 enrolled
NCT07130786 2026-01-27Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain MetastasesBrigham and Women's HospitalPhase 2 Recruiting150 enrolled
NCT06129760 2025-07-09Glioblastoma Remote Monitoring and Care - Research ProtocolCase Comprehensive Cancer CenterPhase NA Recruiting25 enrolled
NCT05059327 2025-06-04Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSCNoema Pharma AGPhase 2 Completed61 enrolled
NCT03098589 2025-03-30Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)CelgeneCompleted1,149 enrolled